Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.

By P. Scanlon, J. Connett, L. Waller, M. Altose, W. Bailey, A. Buist, D. Tashkin. American Journal of Respiratory and Critical Care Medicine, 2000

762 citations recorded by the source corpus.

Subfields: Physiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/cf83239a7e1bae2b5446708fe682cf8c7a96d1ec

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Physiology

1. P. Calverley
2. David M. Mannino
3. D. Parums

In Pulmonary and Respiratory Medicine

1. D. Parums
2. P. Calverley
3. Jorgen Vestbo
4. Bartolome Celli
5. David M. Mannino
6. P. Barnes
7. W. Bailey
8. L. Gerald

Citations in the corpus

• Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. (2008, result): “Our results confirm those of previous studies, which have shown that smoking status, age, and baseline percent predicted FEV1 affect the rate of lung function decline ( 32 ).”
• Gender and chronic obstructive pulmonary disease: why it matters. (2007, background): “5 times greater FEV1% predicted improvement than men (44).”